Transition Bio, Inc. — Form D
Transition Bio, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-04-08. The offering totals $30.6M, of which $30.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-04-08
- Form: D
- Accession: 0001920890-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $30.6M
- Amount sold: $30.6M
- Investors: 23
- Date of first sale: 2022-03-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-441050
Issuer
- Name: Transition Bio, Inc.
- CIK: 0001920890
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: ONE MIFFLIN PLACE, SUITE 400, CAMBRIDGE, MA, 02138
- Phone: 917-445-5573
Officers, directors & promoters (23)
| Name | Role | Location |
|---|
| Shaan K Gandhi | Director | CAMBRIDGE, MA |
| Stephanie L Torruella | Executive Officer | CAMBRIDGE, MA |
| Paxton Major | Director | Austin, TX |
| Tuomas Knowles | Director | Cambridge, MA |
| Tuomas Knowles | Executive Officer | Cambridge, MA |
| Kathy Yi | Director | Cambridge, MA |
| Robert Weeks | Director | Cambridge, MA |
| George Martin | Director | Cambrige, MA |
| George Martin | Executive Officer | Cambrige, MA |
| Al Sandrock | Director | Cambridge, MA |
| Stephanie Torruella | Executive Officer | Cambridge, MA |
| Samuel Cohen | Director | Cambridge, MA |
| Preet Makkar | Executive Officer | Cambridge, MA |
| Connor McDermott | Director | Cambridge, MA |
| Kathy K Yi | Director | CAMBRIDGE, MA |
| Samuel K Cohen | Director | CAMBRIDGE, MA |
| George K Martin | Director | CAMBRIDGE, MA |
| Martin L Kulander | Executive Officer | CAMBRIDGE, MA |
| Connor K McDermott | Director | CAMBRIDGE, MA |
| Tuomas L Knowles | Executive Officer | CAMBRIDGE, MA |
| Gregory L Miller | Director | CAMBRIDGE, MA |
| Gregory L Miller | Executive Officer | CAMBRIDGE, MA |
| Al K Sandrock | Director | CAMBRIDGE, MA |
Other filings by this issuer (3)
More